Dilution, licensing and petlife all discussed in the CC; Link and time marks below
** Petlife specifically is discussed at the beginning of the 3:40 extra continuation of Cc segment that airs immediately after the first segment of the CC - you can find this portion of the CC by simply fast forward to the end of first almost hour long segment and you’ll get to the last 3:40 continuation segment… petlife involvement explained and licensing is further discussed as well ~~~~~~~~~~~~~~~ 41:25 Dilution discussed ** last stage of closing with investors attorney to “avoid future dilution” *** 42:00 investor engaging with FDA LOBBYIST to help FDA process ** investor has experience w distribution of Covid 19 vaccines 42:43 FDA status - discussed “second potential investor” - help to move application from pre Ind to Ind status ~~~~~~~~~~ O:00 petlife (ie at the beginning of 3:40 segment) 1:14 licensing question answer of 3:40 segments) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Meeting link AND passcode to watch - Topic: Medolife Rx (Quanta, Inc. OTC: QNTA) Investor Conference Call Date: May 12, 2022 04:52 PM Eastern Time (US and Canada)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.